[First clinical experience with dihydroergotamine (DHE 45)]
- PMID: 20296721
[First clinical experience with dihydroergotamine (DHE 45)]
Similar articles
-
Migraine headache; treatment of 51 patients with dihydroergotamine.Med Ann Dist Columbia. 1947 Jan;16(1):10-3. Med Ann Dist Columbia. 1947. PMID: 20289912 No abstract available.
-
[Treatment of transformed refractory migraine with intravenous dihydroergotamine].Neurologia. 1999 Jun-Jul;14(6):315-8. Neurologia. 1999. PMID: 10439626 Clinical Trial. Spanish.
-
MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine.Expert Opin Pharmacother. 2012 Sep;13(13):1961-8. doi: 10.1517/14656566.2012.711319. Epub 2012 Aug 4. Expert Opin Pharmacother. 2012. PMID: 22860628 Review.
-
Intravenous dihydroergotamine therapy for pediatric abdominal migraines.Clin Pediatr (Phila). 2013 Oct;52(10):918-21. doi: 10.1177/0009922813492879. Epub 2013 Jul 1. Clin Pediatr (Phila). 2013. PMID: 23820001
-
Orally inhaled dihydroergotamine: a review.Headache. 2013 Sep;53 Suppl 2:43-53. doi: 10.1111/head.12184. Headache. 2013. PMID: 24024602 Review.
Cited by
-
[Changes caused by hydergine and dihydroengotamine in intracranial periperipheral circulation].Klin Wochenschr. 1953 Mar 15;31(11-12):277-80. doi: 10.1007/BF01471713. Klin Wochenschr. 1953. PMID: 13070463 Undetermined Language. No abstract available.
-
[Pathophysiology and clinical aspects of orthostatic circulatory disorders].Arch Kreislaufforsch. 1957 Jan;25(1-3):101-63. Arch Kreislaufforsch. 1957. PMID: 13488471 German. No abstract available.
-
[Use of dehydrated ergot alkaloids (CCK 179, hydergin) in the treatment of disorders of peripheral circulation and in other sympathicotonic disorders; an analytic experiment].Klin Wochenschr. 1950 May 1;28(17/18):298-304. doi: 10.1007/BF01486792. Klin Wochenschr. 1950. PMID: 15437776 Undetermined Language. No abstract available.